KORU Medical Systems Signs Amended Manufacturing and Supply Agreement with Command Medical Products

Reuters11-26
KORU Medical Systems Signs Amended Manufacturing and Supply Agreement with Command Medical Products

KORU Medical Systems Inc. announced that it has entered into an Amended and Restated Manufacturing and Supply Agreement with Command Medical Products, Inc. Under the agreement, effective January 1, 2024, Command will manufacture and supply KORU's subassemblies, needle sets, and tubing products according to KORU's specifications and purchase orders. The agreement is set to expire on December 31, 2026, with automatic one-year renewals unless either party elects not to renew. The agreement outlines terms regarding pricing, payment, purchase commitments, and includes provisions covering delivery, inspection, warranties, quality management, intellectual property, and confidentiality.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KORU Medical Systems Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001161697-25-000426), on November 25, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment